Polygenic Risk Score Testing Market, By Service Type (Sequencing Services, Genotyping Services, Data Analysis and Interpretation, Software / Platforms, and Reporting Solutions), By Sample Type, By Disease Category, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5160
|
Published Date
April 2026
|
Pages
399
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Polygenic Risk Score Testing Market size was valued at US$ 1,600.51 Million in 2025, expanding at a CAGR of 15.89% from 2026 to 2033.
Polygenic Risk Score (PRS) testing is an advanced genetic assessment approach that analyzes multiple genetic variants to estimate an individual’s risk of developing complex diseases. It is widely applied in healthcare for disease risk prediction, preventive screening, and personalized treatment planning.
The Polygenic Risk Score (PRS) testing market includes sophisticated analytical methods that evaluate disease susceptibility using multiple genetic markers. For instance, in 2025, a study referenced by National Institutes of Health indicates that modern genome-wide association studies now analyze tens of thousands of genetic markers (often 10,000–50,000+ SNPs per study) to identify links with complex diseases such as cancer, cardiovascular disorders, and autoimmune conditions. These methods also examine gene sets of 20–100+ SNPs per pathway or cluster, improving detection of weak genetic signals. The increasing genomic complexity and growing use of multi-marker analysis are driving wider adoption of PRS testing in precision medicine.
Polygenic Risk Score Testing Market- Market Dynamics
Rising Awareness Driving Demand for Precision Medicine Growth
The rising demand for precision medicine is driving growth in the Polygenic Risk Score (PRS) testing market, as it enables more accurate prediction of disease risk based on individual genetic profiles, supporting improved prevention strategies and personalized treatment outcomes. For instance, a report from the National Academies of Medicine highlights that precision medicine is expanding rapidly through the integration of large-scale genomic and clinical datasets, enabling more personalized treatment selection. Early clinical applications indicate that around 1 in 5 patients undergoing precision-based interventions experience changes in therapy decisions, while genomic studies show diagnostic yields of approximately 30–35% in previously undiagnosed conditions. The report further emphasizes that precision medicine is increasingly supported by the rapid growth of multi-omics data and real-world health databases across healthcare systems. Recent advances in precision medicine also highlight the growing use of artificial intelligence and multimodal data integration to improve disease prediction, diagnosis, and treatment selection. Precision oncology is expanding through targeted therapies, liquid biopsy technologies, and advanced cancer profiling techniques, while multi-omics and spatial biology approaches are enabling deeper insights into disease behavior at the cellular level.
Polygenic Risk Score Testing Market- Segmentation Analysis:
The Global Polygenic Risk Score Testing Market is segmented on the basis of Service Type, Sample Type, Disease Category, Application, End User, and Region.
In the polygenic risk score (PRS) testing market, genotyping services account for a significant share due to their cost-effectiveness, scalability, and widespread application in identifying genetic variants associated with disease risk across both clinical and research settings. In March 2025, 23andMe expanded its genotyping capabilities by enhancing its consumer genetic testing platform, including the 23andMe+™ Premium Membership and the 23andMe Health + Ancestry Service. These upgrades focused on delivering improved polygenic risk score insights for disease prediction and more personalized health reporting. As a result, genotyping services continue to play a central role in the PRS testing market, driven by their affordability, scalability, and increasing adoption in advanced disease risk assessment and personalized healthcare.
The cardiovascular diseases segment holds a substantial share in the polygenic risk score testing market, largely due to the high prevalence of these conditions and the value of early genetic risk prediction in enabling preventive care and improved disease management. According to the 2026 JACC cardiovascular statistics report, hypertension affects nearly one in two U.S. adults (approximately 50%), making it one of the most common cardiovascular risk factors. The report also indicates that obesity impacts over 40% of the adult population, reflecting a continuing upward trend in risk burden. Additionally, heart failure affects around 6.7 million adults, while coronary heart disease impacts more than 20 million individuals in the United States.
Polygenic Risk Score Testing Market- Geographical Insights
Among geographical regions, North America holds a leading position in the polygenic risk score (PRS) testing market, supported by advanced genomic infrastructure and substantial government funding. Market growth in the region is driven by the expansion of precision medicine initiatives and the increasing adoption of genetic risk assessment tools. For instance, in April 2025, the U.S. government reported that genetic improvement technologies are being increasingly utilized across both research and applied breeding programs, with modern genomic selection methods enabling the analysis of tens of thousands to over 50,000 single nucleotide polymorphisms (SNPs) per individual for trait prediction and improved selection accuracy. Consequently, North America continues to maintain a dominant position in the market, driven by its strong genomics ecosystem, growing precision medicine adoption, and widespread use of advanced genetic analysis technologies.
Japan Polygenic Risk Score Testing Market- Country Insights
Japan is experiencing growth in the polygenic risk score (PRS) testing market, supported by its advanced healthcare infrastructure, increasing emphasis on precision medicine, and growing demand for early disease risk prediction through genetic analysis in both clinical and research applications. For instance, according to JMIR.org, a nationwide survey in Japan involving approximately 40,000 screened participants found that only 5.29% (1,956 of 36,998 respondents) had experienced online medical care, indicating substantial untapped potential for broader clinical adoption of digital and advanced healthcare solutions. Additionally, only 20.4% of healthcare institutions reported adopting online medical care services, with the majority still relying on traditional care delivery models. Overall, despite the relatively low adoption of digital healthcare services, Japan’s PRS testing market demonstrates strong growth potential, driven by increasing integration of precision medicine and expanding use of genetic technologies in healthcare decision-making.
Polygenic Risk Score Testing Market- Competitive Landscape:
The polygenic risk score (PRS) testing market is highly competitive, driven by rapid advancements in genomic technologies, growing demand for personalized healthcare, and continuous innovation in genetic risk assessment solutions. Leading companies such as 23andMe, Myriad Genetics, Color Genomics, Quest Diagnostics, and Illumina are actively expanding their genotyping and sequencing capabilities, strengthening data analytics platforms, and enhancing clinical utility to maintain and strengthen their market positions. In March 2025, Color Health (formerly Color Genomics) expanded its strategic collaborations with major U.S. research and healthcare institutions, reinforcing its role in large-scale genomic screening programs that integrate polygenic risk score–based insights into preventive cancer care and hereditary disease risk assessment initiatives. This reflects the growing integration of PRS tools into preventive healthcare frameworks. Overall, innovation and strategic collaborations continue to accelerate the adoption of polygenic risk score testing in personalized healthcare.
Recent Developments:
- In March 2025, Quest Diagnostics expanded its genomics and precision health capabilities through the acquisition of selected assets from genetic testing and risk assessment platforms. This move strengthened its position in polygenic risk score testing and advanced disease prediction services for clinical and population health applications.
- In January 2025, Illumina enhanced its Polygenic Risk Score Software—Predict Module within the BaseSpace Sequence Hub, enabling improved genotype-to-risk analysis, ancestry-aware risk prediction, and more streamlined reporting for complex disease risk assessment across research and precision medicine applications.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL POLYGENIC RISK SCORE TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- 23andMe
- Myriad Genetics
- Color Genomics
- Quest Diagnostics
- Illumina
- Invitae Corporation
- F. Hoffmann-La Roche
- Thermo Fisher Scientific
- Eurofins Scientific
- BGI Genomics
- Ambry Genetics
- Centogene
- Natera
- QIAGEN
- Personalis
- Others
GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2020 - 2033
- Sequencing Services
- Genotyping Services
- Data Analysis and Interpretation
- Software / Platforms
- Reporting Solutions
- Others
GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2020 - 2033
- Saliva
- Buccal Swab
- Blood
- Others
GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY DISEASE CATEGORY- MARKET ANALYSIS, 2020 - 2033
- Cancer
- Cardiovascular Diseases
- Neurodegenerative Disorders
- Genetic Diseases
- Others
GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Disease Risk Assessment
- Research
- Personalized Medicine
- Others
GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals and Clinics
- Research Institutes
- Pharmaceutical and Biotech Companies
- Others
GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Polygenic Risk Score Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Polygenic Risk Score Testing Market Snippet by Service Type
2.1.2. Polygenic Risk Score Testing Market Snippet by Sample Type
2.1.3. Polygenic Risk Score Testing Market Snippet by Disease Category
2.1.4. Polygenic Risk Score Testing Market Snippet by Application
2.1.5. Polygenic Risk Score Testing Market Snippet by End User
2.1.6. Polygenic Risk Score Testing Market Snippet by Country
2.1.7. Polygenic Risk Score Testing Market Snippet by Region
2.2. Competitive Insights
3. Polygenic Risk Score Testing Key Market Trends
3.1. Polygenic Risk Score Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Polygenic Risk Score Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Polygenic Risk Score Testing Market Opportunities
3.4. Polygenic Risk Score Testing Market Future Trends
4. Polygenic Risk Score Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Polygenic Risk Score Testing Market : Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Polygenic Risk Score Testing Market Landscape
6.1. Polygenic Risk Score Testing Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Polygenic Risk Score Testing Market – By Service Type
7.1. Overview
7.1.1. Segment Share Analysis, By Service Type, 2025 & 2033 (%)
7.1.2. Sequencing Services
7.1.3. Genotyping Services
7.1.4. Data Analysis and Interpretation
7.1.5. Software / Platforms
7.1.6. Reporting Solutions
7.1.7. Others
8. Polygenic Risk Score Testing Market – By Sample Type
8.1. Overview
8.1.1. Segment Share Analysis, By Sample Type, 2025 & 2033 (%)
8.1.2. Saliva
8.1.3. Buccal Swab
8.1.4. Blood
8.1.5. Others
9. Polygenic Risk Score Testing Market – By Disease Category
9.1. Overview
9.1.1. Segment Share Analysis, By Disease Category, 2025 & 2033 (%)
9.1.2. Cancer
9.1.3. Cardiovascular Diseases
9.1.4. Neurodegenerative Disorders
9.1.5. Genetic Diseases
9.1.6. Others
10. Polygenic Risk Score Testing Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Sample Type, 2025 & 2033 (%)
10.1.2. Disease Risk Assessment
10.1.3. Research
10.1.4. Personalized Medicine
10.1.5. Others
11. Polygenic Risk Score Testing Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
11.1.2. Hospitals and Clinics
11.1.3. Research Institutes
11.1.4. Pharmaceutical and Biotech Companies
11.1.5. Others
12. Polygenic Risk Score Testing Market – By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
12.2.1. Overview
12.2.2. Polygenic Risk Score Testing Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.2.4. North America Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.2.5. North America Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.2.6. North America Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.2.7. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Polygenic Risk Score Testing Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.18. Denmark
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.18.3. Denmark Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.3.18.4. Denmark Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.18.5. Denmark Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.3.18.6. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.18.7. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.19. Rest of Europe
12.3.19.1. Overview
12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.19.3. Rest of the Europe Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.3.19.4. Rest of the Europe Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.19.5. Rest of the Europe Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.3.19.6. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.19.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Polygenic Risk Score Testing Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.17. Taiwan
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.17.3. Taiwan Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.4.17.4. Taiwan Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.17.5. Taiwan Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.4.17.6. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.17.7. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.18. Vietnam
12.4.18.1. Overview
12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.18.3. Vietnam Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.4.18.4. Vietnam Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.18.5. Vietnam Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.4.18.6. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.18.7. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.19. Rest of APAC
12.4.19.1. Overview
12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.19.3. Rest of APAC Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.4.19.4. Rest of APAC Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.19.5. Rest of APAC Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.4.19.6. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.19.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Polygenic Risk Score Testing Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Polygenic Risk Score Testing Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.15. Iran
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.15.3. Iran Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.6.15.4. Iran Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.15.5. Iran Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.6.15.6. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.15.7. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.16. Qatar
12.6.16.1. Overview
12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.16.3. Qatar Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.6.16.4. Qatar Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.16.5. Qatar Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.6.16.6. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.16.7. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.17. Rest of MEA
12.6.17.1. Overview
12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.17.3. Rest of MEA Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
12.6.17.4. Rest of MEA Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.17.5. Rest of MEA Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
12.6.17.6. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.17.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13. Key Vendor Analysis- Polygenic Risk Score Testing Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. 23andMe
13.2.2. Myriad Genetics
13.2.3. Color Genomics
13.2.4. Quest Diagnostics
13.2.5. Illumina
13.2.6. Invitae Corporation
13.2.7. F. Hoffmann-La Roche
13.2.8. Thermo Fisher Scientific
13.2.9. Eurofins Scientific
13.2.10. BGI Genomics
13.2.11. Ambry Genetics
13.2.12. Centogene
13.2.13. Natera
13.2.14. QIAGEN
13.2.15. Personalis
13.2.16. Others
14. 360 Degree AnalystView
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL POLYGENIC RISK SCORE TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- 23andMe
- Myriad Genetics
- Color Genomics
- Quest Diagnostics
- Illumina
- Invitae Corporation
- F. Hoffmann-La Roche
- Thermo Fisher Scientific
- Eurofins Scientific
- BGI Genomics
- Ambry Genetics
- Centogene
- Natera
- QIAGEN
- Personalis
- Others
GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2020 - 2033
- Sequencing Services
- Genotyping Services
- Data Analysis and Interpretation
- Software / Platforms
- Reporting Solutions
- Others
GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2020 - 2033
- Saliva
- Buccal Swab
- Blood
- Others
GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY DISEASE CATEGORY- MARKET ANALYSIS, 2020 - 2033
- Cancer
- Cardiovascular Diseases
- Neurodegenerative Disorders
- Genetic Diseases
- Others
GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Disease Risk Assessment
- Research
- Personalized Medicine
- Others
GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals and Clinics
- Research Institutes
- Pharmaceutical and Biotech Companies
- Others
GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
